INO
Inovio Pharmaceuticals, Inc. Common Stock
Nasdaq Global Select$3.9
Open: $3.9 High: $3.955 Low: $3.465 Close: $3.89
Range: 2022-01-24 - 2022-01-25
Volume:6,913,697Market: Extended-hours
Powered by Finage Stock APIDelayed data
INO
Inovio Pharmaceuticals, Inc. Common Stock 660 West Germantown Pike Plymouth Meeting PA, 19462 http://www.inovio.com
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.- CEO: J. Joseph Kim
- Employees: 278
- Sector: Healthcare
- Industry: Biotechnology
INO News
Latest news about the INO
- 2 Stocks That Are Down 60% (or More) From Their 52-Week Highs
One of these stocks is poised to rebound, but the other still looks very risky.
by The Motley Fool at 12/3/21, 12:00 AMView More → - Is Inovio Stock Set to Rebound?
Inovio plans to tackle the omicron variant.
by The Motley Fool at 12/2/21, 12:00 AMView More → - Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen
Both vaccine makers still have big hurdles to jump.
by The Motley Fool at 11/21/21, 12:00 AMView More → - Inovio to start COVID-19 vaccine trial after Brazil regulator's nod by Reuters at 8/26/21, 4:14 PMView More →
- Inovio to start COVID-19 vaccine trial after getting Brazil regulator approval by Reuters at 8/26/21, 12:09 PMView More →